2 results
8-K
EX-99.1
SLP
Simulations Plus Inc.
3 Jan 24
Simulations Plus Reports First Quarter Fiscal 2024 Financial Results
4:06pm
remain resilient as demand for modeling and simulation tools continues to play a greater role in drug development workflow. We remain focused
8-K
EX-99.1
SLP
Simulations Plus Inc.
25 Oct 23
Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results
4:06pm
for continued growth. The underlying fundamentals of our market are resilient, our pipeline is healthy, our profitability is strong, and our balance
- Prev
- 1
- Next